Navigation Links
Research on Crucial Role of PET-Guided Biopsy in Initial Breast Cancer Diagnosis and Presurgical Planning Published in The Breast Journal
Date:3/31/2011

SAN DIEGO, March 31, 2011 /PRNewswire/ -- The Breast Journal recently published original prospective data confirming the technical validity of image-guided needle biopsy of suspicious breast cancer lesions using Positron Emission Mammography (PEM)-guidance.  The study, which used the Naviscan high-resolution breast PET scanner, otherwise known as a PEM scanner, marks the first time PET imaging alone has been able to target regions in the breast with abnormal FDG uptake and guide the extraction for histopathologic analysis.

The main objective of the study was to confirm successful targeting and lesion sampling.  A second objective was to confirm the safety and patient comfort during the procedure. Six physicians, using three different commercially available vacuum-assisted biopsy tools, conducted this study at five sites.  A total of 24 PEM-guided biopsies were completed with 100% success.

The most important advantage of PEM-guided biopsy is the ability to target and biopsy lesions that are difficult to see on other imaging tools giving patients and physicians another option in the fight against breast cancer.  "I am so thankful that I was able to have this procedure," stated Sally Ryser, a patient from Boca Raton, Florida who participated in the study. "The type of cancer that I had is called triple negative and apparently is a very aggressive form of cancer.  Had I not had the PEM scan and the PEM biopsy, who knows what my prognosis would have been had the cancer not been detected.  I truly feel that these innovative PEM procedures most likely saved my life."

"PEM-guided biopsy is quite elegant and confers several advantages over MRI-guided biopsy," stated Dr. Wendie Berg, a co-author of the paper. "We can easily image the breast after sampling to assure removal of the target, and resample at the same setting if needed.  With PEM, we also have the ability to directly image the specimens, which both further confirms successful sampling and allows us to direct the pathologist's attention to the 'hot' specimens."

About Naviscan, Inc.

Naviscan, founded in 1995, develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging and guide radiological and surgical procedures. The Naviscan PEM scanner is currently installed and available in breast and imaging centers throughout the U.S. and other parts of the world. The Company is headquartered in San Diego, California and is the first to obtain FDA-clearance for a high-resolution PET scanner designed to image small body parts and for breast biopsy image guidance.  For more information, call 1.858.587.3641 or visit www.naviscan.com.


'/>"/>
SOURCE Naviscan, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Clinical Research Management, a Full-Service CRO, Changes Its Name to ClinicalRM
2. Southern Research Scientists to Present New Data at the American Association for Cancer Research 102nd Annual Meeting in Orlando
3. Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research
4. Yuma Therapeutics Awarded a Research Grant by the Alzheimers Drug Discovery Foundation to Develop Novel Therapeutics for Alzheimers Disease
5. Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting
6. Bellicum Pharmaceuticals Awarded $5.7 Million by the Cancer Prevention and Research Institute of Texas
7. CVS Caremark Research Finds "Dispense as Written" Prescriptions May Add $7.7 Billion to Annual Health Care Costs
8. Sanofi-aventis Enters Into Research Collaboration With Columbia University to Develop New Diabetes Treatments
9. Pervasis Therapeutics Announces Late-Breaking Oral Presentation at American Association for Cancer Research Annual Meeting
10. Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development
11. Cytel Hires Biopharmaceutical Development Veteran Jim Baker to Support Expansion of its Clinical Research Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
Breaking Medicine News(10 mins):